This enzyme accelerates the absorption and utilization of sugars by increasing the expression of GLUT4, and the increase of insulin receptor sensitivity and insulin resistance is achieved through MAPK phosphorylation to achieve the effect of treating type 2 diabetes [19]. The gene discussed is SLC2A4; the disease is type 2 diabetes mellitus.